Cambrian Bio

Cambrian Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age. To date, we have more than a dozen programs (PipeCos) in our pipeline, including Amplifier Therapeutics (developing a peripherally restricted pan-AMPK activator for the treatment of cardiometabolic diseases), Tornado Therapeutics (developing safer, more effective mTOR inhibitors for extended healthspan), and our latest addition, Telos Biotech (enhancing cell therapies to overcome senescence and exhaustion). We also has programs focused on Women’s Health and Aging (Oviva Therapeutics), Fibrosis (Isterian Biotech), and cellular engineering (Vita Therapeutics).

Company Details

Employees
28
Founded
-
Address
New York, New York 11217, Us
Email
pr****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
New York, New York
Looking for a particular Cambrian Bio employee's phone or email?

Cambrian Bio Questions

News

Cambrian Bio Named an Honoree of Fast Company's Next Big Things in Tech Award - PR Newswire

Cambrian Bio Named an Honoree of Fast Company's Next Big Things in Tech Award PR Newswire

Oviva Therapeutics Appoints Rachel Rimsky Rubin as COO - citybiz

Oviva Therapeutics Appoints Rachel Rimsky Rubin as COO citybiz

Cambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategy - PR Newswire

Cambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategy PR Newswire

Cambrian Bio Launches Telos Biotech to Enable More Robust Cell Therapies - PR Newswire

Cambrian Bio Launches Telos Biotech to Enable More Robust Cell Therapies PR Newswire

Cambrian Bio launches Amplifier Therapeutics to develop clinical-stage AMPK activator - PR Newswire

Cambrian Bio launches Amplifier Therapeutics to develop clinical-stage AMPK activator PR Newswire

Amplifier Therapeutics, a Cambrian Bio pipeline company, doses first patients in Phase 1B clinical trial and closes new financing from Future Ventures and RA Capital Management - PR Newswire

Amplifier Therapeutics, a Cambrian Bio pipeline company, doses first patients in Phase 1B clinical trial and closes new financing from Future Ventures and RA Capital Management PR Newswire

Cambrian Biopharma Closes $100 Million Series C to Advance Healthspan-boosting Therapeutics to the Clinic - PR Newswire

Cambrian Biopharma Closes $100 Million Series C to Advance Healthspan-boosting Therapeutics to the Clinic PR Newswire

Cambrian Biopharma CEO James Peyer Named 2022 "BioTech Company CEO of the Year" By BioTech Breakthrough - PR Newswire

Cambrian Biopharma CEO James Peyer Named 2022 "BioTech Company CEO of the Year" By BioTech Breakthrough PR Newswire

Cambrian Biopharma Announces Licensing Agreement to Develop Selective mTOR Inhibitors - PR Newswire

Cambrian Biopharma Announces Licensing Agreement to Develop Selective mTOR Inhibitors PR Newswire

Top Cambrian Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant